SAB Biotherapeutics Inc. (SABS)
1.60
-0.11 (-6.43%)
At close: Mar 03, 2025, 12:29 PM
SAB Biotherapeutics Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SABS stock have an median target of 9.5, with a low estimate of 6 and a high estimate of 12. The median target predicts an increase of 493.75% from the current stock price of 1.60.
AI Analyst Report
Chardan Capital reaffirms a Buy rating for SAB Bio... Unlock content with Pro Subscription
Updated Jan 29, 2025
Financial Forecast this Year
Revenue This Year
1.32M
from 2.24M
Increased by -40.9%
Revenue Next Year
1M
from 1.32M
Increased by -24.4%
EPS This Year
-3.68
from -7.64
Increased by 51.8%
EPS Next Year
-3.5
from -3.68
Increased by 4.9%